Clinical Trial

Study of IBI3016 in People With Mild or Moderate Hypertension Patients

Name: Study of IBI3016 in People With Mild or Moderate Hypertension Patients — clinical trial record (NCT07556796)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and pharmacodynamic characteristics of a single subcutaneous dose of IBI3016 in Chinese patients with mild to moderate hypertension.

Trial Details

NCT Number	NCT07556796
Lead Sponsor	Innovent Biologics (Suzhou) Co. Ltd.
Conditions	Hypertension
Enrollment	30 participants
Start Date	2026-05-15
Primary Completion	2027-10-16 (estimated)
Study Completion	2027-10-16 (estimated)
Updated on ClinicalTrials.gov	2026-04-29